Fiscal stimulus in China could help boost the world's second-largest economy to 5% GDP growth next year, SocGen analysts ...

Odds of a 50 basis point cut dropped to 0% from 53% last week after the strong September jobs report, according to the CME ...

"EPS could double to $400 by the end of the decade in our Roaring 2020s scenario," Ed Yardeni said in a recent note.

Medicare plans to downgrade ratings on some of the Humana's health insurance plans. The stock has fallen 23% for its worst ...

OnKure is focused on advancing a pipeline of candidates targeting oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα), initially in ...

Verb Technology Company, Inc. (Nasdaq: VERB) ("VERB" or the "Company"), the leader in interactive video-based sales-enablement applications, including MARKET.live, its livestream social shopping ...

New York, New York-- (Newsfile Corp. - October 4, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Ford Motor Company (NYSE: F) and ...

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced today that the Company will ...

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney ...

The gross proceeds to the Company from the registered direct offering are estimated to be approximately $30.0 million, before deducting the placement agent’s fees and other estimated offering expenses ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells, today ...

MRV is an incorporated joint venture owned by ExxonMobil, Eni and CNPC, and holds a 70 percent interest in Area 4. The remaining Area 4 participants are ENH (10%), KOGAS (10%) and Galp (10%).